Cas no 957065-97-3 (4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester)
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester Chemical and Physical Properties
Names and Identifiers
-
- Methyl 3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
- 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester
- Benzoic acid,3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester
- B-5257
- CS-0176497
- BS-24724
- DTXSID40674320
- METHYL3-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
- EN300-363383
- 4-Methoxycarbonyl-2-nitrophenylboronic acid,pinacol ester
- AKOS022177758
- FT-0660075
- 957065-97-3
- F76812
- METHYL 3-NITRO-4-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
- MFCD09878423
- 4-Methoxycarbonyl-2-nitrophenylboronic acid pinacol ester
- DB-112662
-
- MDL: MFCD09878423
- Inchi: 1S/C14H18BNO6/c1-13(2)14(3,4)22-15(21-13)10-7-6-9(12(17)20-5)8-11(10)16(18)19/h6-8H,1-5H3
- InChI Key: WRGJIRHQRSVMFP-UHFFFAOYSA-N
- SMILES: O1B(C2C=CC(C(=O)OC)=CC=2[N+](=O)[O-])OC(C)(C)C1(C)C
Computed Properties
- Exact Mass: 307.12300
- Monoisotopic Mass: 307.123
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 22
- Rotatable Bond Count: 3
- Complexity: 445
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 90.6A^2
Experimental Properties
- PSA: 90.58000
- LogP: 2.20380
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M329680-100mg |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester |
957065-97-3 | 100mg |
$64.00 | 2023-05-17 | ||
| TRC | M329680-250mg |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester |
957065-97-3 | 250mg |
$75.00 | 2023-05-17 | ||
| TRC | M329680-500mg |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester |
957065-97-3 | 500mg |
$87.00 | 2023-05-17 | ||
| TRC | M329680-1g |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester |
957065-97-3 | 1g |
$ 80.00 | 2022-06-03 | ||
| Chemenu | CM219473-5g |
Methyl 3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate |
957065-97-3 | 98% | 5g |
$158 | 2022-08-31 | |
| abcr | AB273528-1 g |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester; 98% |
957065-97-3 | 1g |
€110.00 | 2023-04-26 | ||
| abcr | AB273528-5 g |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester; 98% |
957065-97-3 | 5g |
€314.00 | 2023-04-26 | ||
| TRC | M329680-1000mg |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester |
957065-97-3 | 1g |
$98.00 | 2023-05-17 | ||
| Chemenu | CM219473-5g |
Methyl 3-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate |
957065-97-3 | 98% | 5g |
$158 | 2021-08-04 | |
| Enamine | EN300-363383-0.05g |
methyl 3-nitro-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate |
957065-97-3 | 0.05g |
$624.0 | 2023-03-02 |
4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester Related Literature
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
-
Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
Additional information on 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester
Introduction to 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester (CAS No. 957065-97-3) and Its Emerging Applications in Chemical Biology
The compound 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester (CAS No. 957065-97-3) represents a fascinating intersection of organic chemistry and pharmaceutical innovation. Boronic acid esters, particularly those derived from nitrophenyl or methoxycarbonyl-substituted aromatic rings, have garnered significant attention in recent years due to their versatile reactivity and utility in synthetic chemistry. This boronic acid derivative, featuring a pinacol ester moiety, is particularly noteworthy for its role in cross-coupling reactions and its potential applications in drug discovery and molecular recognition.
Boronic acids are well-known for their ability to participate in reversible interactions with diols, a property that has been leveraged in various biochemical assays and as key intermediates in Suzuki-Miyaura cross-coupling reactions. The 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester structure combines the electron-withdrawing effect of the nitro group with the electron-donating influence of the methoxycarbonyl group, creating a molecule with distinct electronic and steric properties. These characteristics make it an attractive candidate for further functionalization and derivatization in synthetic protocols.
In recent years, there has been a surge in research exploring the applications of boronic acid derivatives in medicinal chemistry. The nitrophenyl moiety, in particular, has been extensively studied for its potential as a pharmacophore due to its ability to modulate enzyme activity and interact with biological targets. The 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester is no exception, and its incorporation into drug-like molecules has shown promise in preclinical studies. For instance, modifications of this scaffold have been investigated for their potential role in inhibiting enzymes involved in inflammatory pathways.
The pinacol ester group provides stability to the boronic acid moiety under various reaction conditions, making it a preferred choice for applications requiring high thermal or chemical stability. This stability is crucial for pharmaceutical intermediates, where degradation could compromise the efficacy of the final drug product. Furthermore, the boronic acid-pinacol ester linkage can be selectively cleaved under specific conditions, allowing for controlled release of active pharmaceutical ingredients (APIs) or diagnostic agents.
One of the most compelling aspects of 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester is its utility in biorthogonal chemistry. Biorthogonal reactions enable the selective modification of biomolecules without disrupting native biological processes, making them invaluable tools for probing biological pathways and developing novel therapeutics. The boronic acid component can react with azides via a Sonogashira coupling or undergo other transformations that are orthogonal to biological systems, facilitating targeted labeling and tracking of biomolecules in vivo.
Recent advances in computational chemistry have also highlighted the potential of this compound as a scaffold for drug design. Molecular modeling studies suggest that derivatives of 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester can interact with specific pockets on target proteins through hydrogen bonding networks formed by the nitro group and methoxycarbonyl moiety. These interactions have been predicted to modulate protein conformational changes that could lead to therapeutic effects.
The synthesis of 4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester typically involves multi-step organic transformations starting from readily available nitroaromatic precursors. The introduction of the methoxycarbonyl group followed by protection as a pinacol ester ensures compatibility with subsequent cross-coupling reactions. Recent improvements in synthetic methodologies have streamlined these processes, reducing reaction times and improving yields—advancements that are critical for scaling up production for pharmaceutical applications.
The growing interest in this compound is also driven by its potential as an imaging agent. Boron-containing compounds have been explored as contrast agents for magnetic resonance imaging (MRI) due to their ability to enhance relaxivity parameters when localized near tumors or other pathological sites. The nitro group's paramagnetic properties can be exploited to create contrast agents that provide high-resolution images without the need for exogenous paramagnetic ions like gadolinium.
In conclusion,4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester (CAS No. 957065-97-3) represents a promising chemical entity with diverse applications spanning synthetic chemistry, drug discovery, and medical imaging. Its unique structural features—combining a nitrophenyl ring with a methoxycarbonyl-substituted boronic acid pinacol ester—make it an ideal candidate for further exploration by researchers seeking innovative solutions to complex biochemical challenges.
957065-97-3 (4-Methoxycarbonyl-2-nitrophenylboronic acid, pinacol ester) Related Products
- 957061-12-0(3-Methoxycarbonyl-5-nitrophenylboronic acid, pinacol ester)
- 1218791-11-7(4-Carboxy-2-nitrophenylboronic acid, pinacol ester)
- 377780-80-8(3-Carboxy-5-nitrophenylboronic acid, pinacol ester)
- 1268336-13-5(3-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate)
- 1256359-10-0(4,4,5,5-Tetramethyl-2-(4-methyl-2-nitrophenyl)-1,3,2-dioxaborolane)
- 850689-27-9(Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate)
- 850567-50-9(3-Amino-5-methoxycarbonylphenylboronic acid, pinacol ester, hydrochloride)
- 524916-42-5(Methyl 4-amino-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate)
- 85107-55-7((4-(methoxycarbonyl)-2-nitrophenyl)boronic acid)
- 850567-49-6(methyl 3-amino-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate;hydrochloride)